{"paper_id":"35dcc951-2032-4324-a611-a5c51ce015b7","body_text":"Page 1/13\nThe effect of broccoli extract and soy isoavones\non endometrial implants and oxidative parameters\nin female rat model of endometriosis\nSoudabeh Sabetian \nInfertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran\nParimah Archin Dialameh \nDepartment of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences,\nShiraz, Iran\nNader Tanideh \nDepartment of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran\nBehrooz Gharesifard \nDepartment of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran\nMoslem Ahmadi \nDepartment of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran\nMaryam Valibeigi \nDepartment of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran\nPerikala Vijayananda Kumar \nDepartment of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran\nSarah Siahbani \nDepartment of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran\nBahia Namavar Jahromi  (  namavarprc@gmail.com )\nDepartment of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences,\nShiraz, Iran\nResearch Article\nKeywords:\nPosted Date: December 15th, 2022\nDOI: https://doi.org/10.21203/rs.3.rs-2369250/v1\nLicense:   This work is licensed under a Creative Commons Attribution 4.0 International License.  \nRead Full License\n\nPage 2/13\nAbstract\nBackground: Endometriosis is a gynecological disorder characterized by the growth of endometrial tissue\noutside the uterine cavity that is associated with chronic pelvic pain, subfertility and 1-3% increased risk\nof ovarian cancer. The purpose of the study was to investigate the effect of broccoli extract (BE) alone\nand in combination with soy isoavones (SI) on endometrial implants in female rat.\nMethod: In this study, endometriosis was induced surgically in 40 mature female rats. The rats were\ndivided into 5 groups that were treated by oral gavage for 6 weeks with 0.5 ml of saline 0.9%/day (control\ngroup), BE (3000 mg/kg/day), SI (50mg/kg/day), BE/soy isoavones (BE 3000 mg/kg/day + soy\nisoavones 50mg/kg/day) and diphereline as a standard medication (3 mg/kg) intramuscularly. At the\nend of treatments, the volume and histopathology of the endometrial implants were compared among the\n5 groups. The serum levels of oxidative parameters including Superoxide dismutase (SOD),\nMalondialdehyde (MDA) and tumor necrosis factor alpha (TNF- α ) were also compared between the\ngroups.\nResults: The volume of the implants signicantly decreased in diphereline group (p = 0.002). The\nhistopathological grade of endometrial implants in BE/SI and diphereline group were signicantly\ndecreased compared to the control group (p = 0.001). The serum levels of SOD in BE group were\nenhanced signicantly in comparison to the control group (p = 0.034).\nConclusion: BE in combination with SI decreased the growth and histopathologic grades of transplanted\nendometrial implants. These herbal compounds may have the potential to be used as an alternative\nmedication for the treatment of endometriosis\nIntroduction\nEndometriosis is a medical condition that occurs when the tissues of uterine lining grow in other pelvic\norgans, such as the ovaries or fallopian tubes [1]. Bleeding the endometrial tissue outside the uterus may\ncause pain, dysmenorrhea, and infertility [2]. Endometriosis occur in a unique environmental condition\ncharacterized by enhanced hormonal concentrations, inammation, and oxidative stress [3].\nGonadotropin releasing hormone agonists (GnRHa) such as diphereline, as standard hormonal treatment,\ncan regress endometriosis by suppression of hypothalamic-pituitary-gonadal (HPG) axis and ovarian\nestrogen production. The side effects of GnRha include amenorrhea, hot ush, depression, headache, hair\nloss, musculoskeletal stiffness, vaginal dryness and bone loss [4]. Although surgical removal of the\nlesions or induction of a hypoestrogenic state is used as the current treatment, recurrence of lesions is\ncommon and is less than ideal for women in the reproductive ages [5]. Therefore, additional strategies are\nrequired for the treatment of endometriosis [6]. Epidemiologic studies represent an anticancer effect of\ndiet-derived bioactive sulforaphane against different type of cancers such as thyroid and ovarian cancer\n[7]. Cruciferous vegetables, particularly broccoli has a high content of sulforaphane, derived from the\nbreakdown of glucoraphanin, that is capable of modulating the secretion of the proinammatory\n\nPage 3/13\ncytokines such as interleukin-1 beta (IL-1 β ), interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF- α )\n[8, 9]. Although the exact pathogenic mechanisms of endometriosis remain unknown [10], it shows a\ntumoral behavior with tendency to inappropriate growth and adhesion formation [11]. There are a few\nreports on the use of dietary components as chemopreventive agents to improve endometriosis [12]. Soy\nisoavones (SI) are people's daily diet with antitumoral functions; there are reports on a correlation\nbetween high levels of SI in the urine with decreased risk of endometriosis [13, 14]. SI triggered regression\nof endometriotic implants, marked by decreasing size of the lesions and also prohibited the increase in\nproinammatory cytokines, NF-kB activation and estrogen receptor expression in a mice model of\nendometriosis [15]. Superoxide dismutase (SOD) is an important enzyme involved in antioxidant system\n[16]. SOD catalyzes the dismutation of superoxide into hydrogen peroxide and oxygen [17]. SOD shows a\ndecreased activity in the plasma of women with endometriosis, suggesting a decreased antioxidant\ncapacity in these women [18]. Malondialdehyde (MDA) is an organic compound that occurs naturally as\nthe enol, and is a marker for oxidative stress [19]. A higher level of MDA in the serum of women with\nendometriosis was previously observed [20]. It has been demonstrated that SI and sulforaphane\nmodulate oxidative stresses and enhance antioxidative status against oxidative damage to the cells [21,\n22]. In the current study, we aim to compare anti-progressive effects of broccoli extract, soy isoavones\nand combination of these compounds on endometriosis lesions, inammatory cytokines including TNF- α\nand antioxidant marker including MDA and SOD within peritoneal tissue in rat model of induced\nendometriosis. The achieved results were compared with diphereline treatment.\nMethods\nExperimental case-control study Animals\nIn this study, 45 mature female Sprague- Dawley rats (almost 8 weeks old, weighting 220 ± 20 g) were\ncollected and housed at 22 ° C with a 12-h light/dark cycle and had free access to standard rodent chow\nand tap water.\nPreparation of broccoli extract and soy isoavones solution\nBroccoli sprouts was air-dried, powdered and an alcoholic extract was produced by using ethanol (80%)\nand percolation method. Then, solvent was completely removed by drying under reduced pressure in a\nrotary evaporator. The extract was stored at 4° C until use. Soy tablet (Soya Gol, Gol Daru Company, Iran)\nwas dissolved in saline 0.9% (1 tablet includes 50 mg soy isoavones ( ≈  27 mg Genistein))\nInduction of endometriosis\nEndometriosis was induced surgically using the method described by Vernon and Wilson with little\nmodications [25]. Briey, all the female rats were anesthetized using ketamine hydrochloride 10% (100\nmg/kg, Alfasan, Netherlands) and xylazine 2% (10 mg/kg, Alfasan, Netherlands). Then, abdomen was\nopened through 4 cm midline incision starting from 1 cm below the xiphoid. The left horn of uterus was\nligated at both the uterotubal and cervical junction ends and removed. A longitudinal cut was made\n\nPage 4/13\nthrough the uterine horn. By a punch biopsy, 4 round pieces of the distal part of uterine tissue was\nexcised (4× 4× 1 mm) and placed in warm sterile saline 0.9%. Two implants were sutured with proline 5 − \n0, one on the left and the other on the right side of the peritoneal cavity on the areas of well-visible\nvasculature with endometrial surface facing the peritoneum. Finally, the abdominal muscles, fascia and\nskin were sutured. Then, chlortetracycline was sprayed on the incisions site and animals was allowed to\nrecover from anesthesia. Six weeks after the rst surgery, a second look laparotomy was performed and\nthe viability of endometrial implants was conrmed by observation of good vascular supply and pinkish\ncolored tissue in contrast to necrosis and brosis (Fig. 1).\nTreatments\nAt this stage, 45 female rats were divided into 5 groups (9 rats in each group). The control group was\ntreated by 0.5 ml of saline 0.9%/day, the second group by BE (3000 mg/kg/day), the third group by SI (1\ntablet  ≈  50mg isoavones/kg/day)) and the fourth group was taken BE enriched with soy isoavones (BE\n3000 mg/kg/day + soy isoavones (1 tablet  ≈  50mg soavones/kg/day)). All the treatments of four\ngroups were administered by oral gavage. The fth group was received a single IM injection of\ndiphereline S.R. 11.25 mg (3 mg/kg, Ipsen, France). Six weeks after the treatments, the rats were\nsacriced, and the endometrial implants were evaluated.\nMeasurement of the volume of endometriosis lesions\nThe length, width and height of each endometrial lesion was measured in ve groups using collis rulers.\nThe volume of the endometriotic nodules was calculated by ellipsoid volume formulation ( π /6×length×\nwidth× height).\nPathologic scoring of implants\nAll of the endometrial lesions were xed in formalin, placed in paran, cut into 5 µ m sections, stained\nwith hematoxylin-eosin and evaluated by pathologist. The persistence of epithelial cells in the grafts was\nscored based on the scoring system applied by Keenan et al accordingly, score 0, 1, 2 and 3 show no\nepithelial layer, poorly, moderately and well-preserved epithelial layers, respectively [26].\nDetermination of inammatory cytokines and antioxidant markers\nTissue samples from the lower anterior abdominal wall were taken and homogenized in Trizol reagent\n(Life Technologies, Burlington, Ontario, Canada). Each homogenate was centrifuged for 30 min at 800 g.\nTotal protein in this extract was assayed using a standard protein assay method (BioRad DC Protein\nAssay BioRad Laboratories, Mississauga, Canada). Equal quantities of protein were used to determine\nSOD activity by Activity Assay Kit (ZellBio GmbH, Germany), MDA levels by MDA Assay Kit (crystal day\nBiotech Co., Ltd, China), TNF-&alpha by Rat TNF alpha ELISA Kit (crystal day Biotech Co., Ltd, China).\nAnalysis was done according to the detail procedures in the kit.\nStatistical analysis\n\nPage 5/13\nData are presented as mean ± SD and the difference between groups was analyzed using proper tests\n(parametric or non-parametric) by SPSS according to distribution of the data. Only probability values of\nP < 0.05 was considered signicant. The ow chart of the study is displayed in Fig. 2.\nResults\nThe mean of volume values of endometrial implants in Diphereline group was signicantly decreased (P \n= 0.002) and the implants' volume was stepped down considerably in BE/SI group compared to control\ngroup even though the difference was not signicant (Table 1).\nTable 1\nThe mean volume of endometrial implants\nGroups Implants' volume (mm3)\n  Mean ± SD p value 1* p value 2*\nControl 86.77 ± 73.13 ----- -----\nBroccoli Extract 56.60 ± 52.12 0.36 0.01\nSoy Isoavone 78.46 ± 73.72 0.80 0.03\nBroccoli Extract/Soy Isoavone 42.02 ± 31.88 0.13 ≤  0.01\nDiphereline 2.22 ± 2.07 ≤  0.01 -----\n*p value 1: Comparing to Control; p value 2: Comparing to Diphereline\nThe histopathological score of endometrial implants in BE/SI and diphereline group were signicantly\ndecreased compared to the control group (p = 0.001) and there was no signicant change in the score in\nrats treated with BE/SI compared to diphereline group (p = 0.90) (Table 2) & Fig. 3.\nTable 2\nThe histopathological grade of endometrial implants\nGroups Pathological score\nMean ± SD p value 1* p value 2*\nControl 2.08 ± 0.44 ---- ------\nBroccoli Extract 1.66 ± 0.44 0.08 0.02\nSoy Isoavone 1.80 ± 0.32 0.17 ≤  0.01\nBroccoli Extract/Soy Isoavone 1.2 ± 0.41 ≤  0.01 0.90\nDiphereline 1.2 ± 0.27 ≤  0.01 -----\n*p value 1: Comparing to Control; p value 2: Comparing to Diphereline\n\nPage 6/13\nD & E) Broccoli Extract/Soy Isoavone and Soy Isoavone groups respectively: Poorly preserved epithelial\nlayer of endometrial implants (grade 1).\nTable 3\nThe level of serum MDA and SOD\nGroups MDA (nmol/ml) SOD (U/ml) TNF- α  (pg/ml)\nMean ± SD pvalue Mean ± SD pvalue Mean ± SD pvalue\nControl 2.90 ± 1.024 ----- 92.00 ± 20.43 ----- 20.63 ± 10.50 -----\nBroccoli Extract 2.86 ± 0.817 0.23 112.07 ± 14.87 0.03 21.74 ± 11.39 0.85\nSoy Isoavone 2.75 ± 1.05 0.63 92.97 ± 26.84 0.98 19.41 ± 11.98 0.83\nBroccoli Extract/SoyIsoavone 2.81 ± 0.711 0.06 101.72 ± 17.08 0.24 25.77 ± 10.61 0.38\nDiphereline 2.27 ± 0.438 0.19 96.38 ± 29.35 0.81 15.18 ± 4.66 0.24\nThe serum level of MDA in the studied groups was not signicantly different and the level of serum SOD\nin broccoli group was enhanced signicantly in comparison to the control group (p = 0.034) (Table 3).\nDiscussion\nEndometriosis is characterized by the existence of endometrial tissue outside the uterus and exact\nphysiopathology is not well known [23]. Surgical and hormonal treatment of endometriosis have\ninappropriate side effects and high rates of recurrence. Recent studies have demonstrated the benecial\neffect of herbal medicine against endometriosis [24]. In the current study, we compared the therapeutic\neffects of broccoli extract and soy isoavones on endometriosis lesions, inammatory cytokines\nincluding TNF- α  and serum levels of antioxidant markers including MDA and SOD in a rat model of\ninduced endometriosis. The achieved results were compared with hormone therapy (gonadotropin-\nreleasing hormone: diphereline). Endometriosis is associated with inammation along with oxidative\nstress, thereby weakening the oxidative and inammatory potential is the main strategy of the effective\ntherapeutic roles of phytochemicals on the control of endometriosis [25, 26]. Sulforaphane, a compound\nderived from broccoli sprouts is an agent to mediate anti-oxidant and anti-inammatory activity [27]. Soy\nisoavones including genistein and daidzein modulate the estrogen receptor and inhibit cell growth and\ninammation in endometriosis [28]. It was demonstrated the potential preventive effects of isoavones\non endometriosis progression through the control of apoptosis dysregulation, the inhibition of NF- κ B and\nCOX-2 pathways in the peritoneal tissues [29]. In this study, the mean implants' volume in the treatment\nwith broccoli extract mixed with soy isoavones (42.02 ± 31.88 mm3) was decreased considerably\n\nPage 7/13\ncompared with control (86.77 ± 73.13 mm3) even though the difference was not signicant statistically\n(p = 0.13). Interestingly, the histopathological score of Broccoli/Soy group showed poorly epithelial layers\nwith signicant regression compared to the control group. The results may imply the synergistic\nphytopreventive effects of isoavones and sulforaphane on endometriosis development. SOD is an\nimportant enzyme in antioxidant system that catalyzes the dismutation of superoxide into hydrogen\nperoxide and oxygen [30]. Activity of SOD was shown to be decreased in the plasma of women with\nendometriosis, suggesting a declined antioxidant capacity in these women [31]. In the present study, the\nserum level of SOD was increased signicantly after broccoli exctract treatment and was enhanced\ninsignicantly in other studied groups. It was reported that broccoli exctract protects the cells from H2O2-\ninduced oxidative stress through enhancing Nrf2/Keap1 signaling pathway consequently augmenting\nantioxidant enzyme such as SOD [32]. Isoavone supplementation was illustrated to enhance antioxidant\naction via weakening of exercise-induced oxidative stress [33]. The previous studies have demonstrated\nthat serum MDA was signicantly reduced by dietary Supplement of Broccoli and soy isoavones [34].\nThe current ndings showed no signicant effects of the studied treatments on MDA. Previous studies\nhave represented that the volume of endometriosis lesions was signicantly decreased simultaneously\nwith a reduction in the level of IL-6, TNF- α , estradiol and vascular endothelial growth factor (VEGF) within\nserum and peritoneal uid [35]. It has been corroborated that dietary supplements including sulforaphane\nand isoavones decrease the levels of anti-inammatory cytokines such as TNF- α  and nuclear factor\nkappa B (NF- κ B), that are involved in the mechanism of inammation [36, 37]. However, Serum levels of\nTNF- α  showed no signicant statistical difference among the treated groups in the current study. These\nincompatibilities might be due to the treatment duration and dosages of the compounds. Dipherelin\nshowed the lowest and BE/ SI showed the highest levels of TNF- α  in our study.\nConclusion\nDietary consumption of broccoli extract in combination with soy isoavones signicantly reduced the\nhistopathologic grades of endometrial implants in female rat model of endometriosis. The volume of\nendometrial implants was decreased considerably in the treated rats by mixed broccoli extract and soy\nisoavones. The serum level of SOD was signicantly increased by broccoli extract treatment and\ninsignicantly in other studied groups. The ndings of the current study show the potential preventive\neffect of the combination of broccoli extract and soy isoavones on endometriosis. Further studies are\nrequired to prove the benecial properties of these compounds on the clinical symptoms of\nendometriosis.\nDeclarations\nAcknowledgements\nNone.\nFunding\n\nPage 8/13\nThis article has been nancially supported by the Vice Chancellor for Research of Shiraz University of\nMedical Sciences with the grant number of 97-01-50-19167.\nAuthor information\nAuthors and Aliations\nInfertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran\nSoudabeh Sabetian, Behrooz Gharesifard, Bahia Namavar Jahromi\nDepartment of Obstetrics and Gynecology, School of Medicine, Shiraz University of Medical Sciences,\nShiraz, Iran\nParimah Archin Dialameh, Bahia Namavar Jahromi\nDepartment of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran\nNader Tanideh\nDepartment of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran\nBehrooz Gharesifard, Moslem Ahmadi, Maryam Valibeigi\nDepartment of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran\nPerikala Vijayananda Kumar, Sarah Siahbani\nContributions\nSSa and BNJ contributed to the study design and conceptualization. SSa, PAD, NT, BGh, MA, MV, PVK and\nSSi provided technical support and critically reviewed the manuscript for its intellectual content. SSa and\nBNJ reviewed the literature and performed the analysis. All authors read and approved the nal\nmanuscript.\nCorresponding author\nCorrespondence to Bahia Namavar Jahromi.\nEthics declarations\nEthics approval and consent to participate\nThe Medical Ethics Committee of Shiraz University of Medical Sciences approved this study with the\nreference number IR.SUMS.REC.1398.176.\nConsent for publication\n\nPage 9/13\nNot applicable.\nCompeting interests\nThe authors declare that they have no competing interests.\nReferences\n1. Arafah M, Rashid S, MJ.A.i.AP Akhtar. Endometriosis: a comprehensive review. 2021;28(1):30–43.\n2. Español F, Endometriosis is a disease where tissue similar to the lining of the uterus grows outside\nthe uterus, causing pain and/or infertility (1). Endometriosis affects roughly 10%(190 million) of\nreproductive age women and girls globally (2). It is a chronic disease associated with severe, life-\nimpacting pain during periods, sexual intercourse, bowel movements and/or urination, chronic pelvic\npain, abdominal bloating, nausea. 2021.\n3. Assaf L, Eid AA, Nassif JJLS, Role of ampk/mtor, mitochondria, and ros in the pathogenesis of\nendometriosis. 2022: p. 120805.\n4. Jahromi BN, et al., Comparing the effects of glycyrrhiza glabra root extract, a cyclooxygenase-2\ninhibitor (celecoxib) and a gonadotropin-releasing hormone analog (diphereline) in a rat model of\nendometriosis. 2019. 13(1): p. 45.\n5. Clemenza S, et al. Endometriosis-Induced Pain: The Treatment Strategy, in Endometriosis\nPathogenesis, Clinical Impact and Management. Springer; 2021. pp. 41–50.\n. Guo Y, et al., Complementary and alternative medicine for dysmenorrhea caused by endometriosis: a\nreview of utilization and mechanism. 2021. 2021.\n7. Deldar Abad Paskeh M, et al. Target cancer stem cells Diet agents: important therapeutic strategy\nagainst Hum malignancies. 2021;22(21):11669.\n. Mangla B, et al., Sulforaphane: A review of its therapeutic potentials, advances in its nanodelivery,\nrecent patents, and clinical trials. 2021. 35(10): p. 5440–5458.\n9. Moon S-J, et al., The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with\ninhibition of both B cell differentiation and the production of inammatory cytokines. 2021. 16(2):\np. e0245986.\n10. Polak G, et al. Environ Factors Endometr. 2021;18(21):11025.\n11. Sun Y, Liu GJJoC. Endometriosis-associated Ovarian Clear Cell Carcinoma: A Special Entity?\n2021;12(22):6773.\n12. George BP, Chandran R, Abrahamse HJA. Role of phytochemicals in cancer chemoprevention:\ninsights. 2021;10(9):1455.\n13. Kim I-SJA. Current perspectives on the benecial effects of soybean isoavones and their\nmetabolites for humans. 2021. 10(7): p. 1064.\n14. Fan Y, et al. Intake of Soy, Soy Isoavones and Soy Protein and Risk of. Cancer Incidence and\nMortality. 2022;9:847421.\n\nPage 10/13\n15. Cai X, et al., Phytoestrogens for the management of endometriosis: ndings and issues. 2021. 14(6):\np. 569.\n1. Cecerska-Hery ć  E, et al., Are antioxidant enzymes essential markers in the diagnosis and monitoring\nof cancer patients–a review. 2021. 93: p. 1–8.\n17. Senthilkumar M, Amaresan N, Sankaranarayanan A. Estimation of superoxide dismutase (SOD), in\nPlant-microbe interactions. Springer; 2021. pp. 117–8.\n1. Udayana IGNBS, et al. Association of Endometriosis and Oxidative Stress. 2022;4(5):109–13.\n19. Labib H, et al., Keap1/Nrf2 pathway in sodium uoride-induced cardiac toxicity and the prophylactic\nrole of vitamin C versus platelet-rich plasma. 2022. 81(3): p. 663–678.\n20. Da Broi MG, et al., The Impact of Controlled Ovarian Stimulation on Serum Oxidative Stress Markers\nin Infertile Women with Endometriosis Undergoing ICSI. 2022. 11(6): p. 1161.\n21. Yadav E, et al. Polyphenols as Modulators of Oxidative Stress in Cancer Disease, in Polyphenols-\nbased Nanotherapeutics for Cancer Management. Springer; 2021. pp. 143–88.\n22. Jurcau AJN, The role of natural antioxidants in the prevention of dementia—where do we stand and\nfuture perspectives. 2021. 13(2): p. 282.\n23. Marcolongo P, et al., Regulation of autophagy in the uterus: from physiological processes to\nendometriosis and uterine broids. 2021.\n24. Meresman GF, Götte M. and M.W.J.H.r.u. Laschke, Plants as source of new therapies for\nendometriosis: a review of preclinical and clinical studies. 2021. 27(2): p. 367–392.\n25. Iftikhar M, et al. Assessment of Lipid Prole in Females Suffering from Endometriosis. in\nProceedings. 2022.\n2. Cacciottola L, Donnez J, M.-M.J.I.J.o.M S, Dolmans. Can endometriosis-related oxidative stress pave\nthe way for new treatment targets? 2021. 22(13): p. 7138.\n27. Mahn A, Castillo AJM. Potential of sulforaphane as a natural immune system enhancer: A review.\n2021. 26(3): p. 752.\n2. Maksymowicz M, et al., The role of soy in development of breast, ovarian, endometrial and prostate\ngland cancer. 2021. 11(9): p. 180–186.\n29. Go łą bek A, Kowalska K, Olejnik AJN. Polyphenols as a Diet Therapy Concept for Endometriosis—\nCurrent Opinion and Future Perspectives. 2021. 13(4): p. 1347.\n30. Fujii J, Homma T, Osaki TJA. Superoxide Radicals in the Execution of Cell Death. 2022;11(3):501.\n31. Lu J, et al., Emerging hallmarks of endometriosis metabolism: A promising target for the treatment of\nendometriosis. 2022: p. 119381.\n32. Lee D-Y, Song M-Y, Kim E-HJA. Role of oxidative stress and Nrf2/keap1 signaling in colorectal cancer:\nMechanisms and therapeutic perspectives with phytochemicals. 2021. 10(5): p. 743.\n33. Zeng Z, et al., Effects of dietary strategies on exercise-induced oxidative stress: a narrative review of\nhuman studies. 2021. 10(4): p. 542.\n\nPage 11/13\n34. Nazari-Khanamiri F, MJ.J.o.FB Ghasemnejad ‐ Berenji. Cellular and molecular mechanisms of\ngenistein in prevention and treatment of diseases: An overview. 2021. 45(11): p. e13972.\n35. Lu F, et al., Antibiotic Therapy and Vaginal Microbiota Transplantation Reduce Endometriosis\nDisease Progression in Female Mice via NF- κ B Signaling Pathway. 2022. 9.\n3. Pérez-Torres I, et al., Oxidative stress, plant natural antioxidants, and obesity. 2021. 22(4): p. 1786.\n37. Zamani-Garmsiri F, et al., Polyphenols: Potential anti ‐ inammatory agents for treatment of metabolic\ndisorders. 2022. 36(1): p. 415–432.\nFigures\nFigure 1\nInduction of endometriosis. A) The rst laparotomy: transplant of endometrial implants on the\nperitoneum. B) The second look surgery: necropsy of a rat in the control group showing growth of\nimplanted lesions of endometriosis.\n\nPage 12/13\nFigure 2\nThe ow chart of the study\n\n\nPage 13/13\nFigure 3\nSpecimens of the treated groups stained by hematoxylin-eosin (scale bar: 100 μ m). A) Control group: well\npreserved epithelial layer of endometrial implants (grade 3), B & C) Broccoli Extract and Soy Isoavone\ngroups respectively: Moderately preserved epithelial layer of endometrial implants (grade 2).\nD & E) Broccoli Extract/Soy Isoavone and Soy Isoavone groups respectively: Poorly preserved epithelial\nlayer of endometrial implants (grade 1).","source_license":"CC0","license_restricted":false}